Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19)

Methodist Health System417 enrolled

Overview

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals

Multicenter retrospective chart review of patients admitted to any of the four Methodist Health System hospitals (Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas) between February 1 and April 30, 2020. All study center utilize Epic ® electronic health record (Verona, Wisconsin; www.epic.com) for which all data will be extracted from.

Study Type

OBSERVATIONAL

Enrollment

417

Conditions

COVID-19

Interventions

ObservationalOTHER

Observational

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients admitted to Methodist Richardson, Methodist Mansfield, Methodist Charlton, or Methodist Dallas Medical Centers between February 1, 2020 and April 30, 2020 * \>18 years old * Positive SARS-CoV-2 (COVID-19) PCR test Exclusion Criteria: * Outpatient or emergency department visit * Not admitted to an inpatient or observation status for \>24 hours

Locations (1)

Methodist Dallas Medical Center

Dallas, Texas, United States

Outcomes

Primary Outcomes

Prevalence of subsequent and co-infections

Time frame: Feb 2020 - April 2020

Secondary Outcomes

In-hospital mortality

Time frame: Feb 2020 - April 2020

Hospital length of stay (LOS)

Time frame: Feb 2020 - April 2020

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.